Novozymes and
Chr. Hansen to combine

and create a leading global biosolutions partner

Conference call

A conference call will be hosted on December 12 at 9:00am CET.
The call can be followed live or watched as a replay.

To ask questions, please pre-register here.

Key documents

Announcements

Notice convening the extraordinary general meeting 2024


Completion of the combination between Novozymes and Chr. Hansen


Retail brochure (in Danish only, January 2024)


All necessary regulatory approvals have been obtained for the combination of Novozymes and Chr. Hansen


Novozymes and Chr. Hansen announce name of future combined company


Conditional competition clearance from the European Commission obtained


Update on merger EC offered remedy proposal


Executive Leadership Team and organizational structure announced for the future combined company of Novozymes and Chr. Hansen


Stock exchange announcement regarding approval of combination by Novozymes shareholders


Investor news on the approval of combination by the Novozymes shareholders and Chr. Hansen shareholders


Press release on the approval of combination by the Novozymes shareholders and Chr. Hansen shareholders 


Investor news on U.S. antitrust regulation


Investor news on Chinese merger approval


Stock exchange announcement regarding exemption document


Stock exchange announcement regarding proposed merger


Press release regarding proposed merger


Exemption document and related documents

Exemption document (for other jurisdictions than Australia)


Exemption document for shareholders of Chr. Hansen Holding A/S residing in Australia 


Retail brochure (in Danish only, March 2023)


Merger documents

Merger plan


Merger statement


Tax-exempt merger ruling


Auditor documents

Valuer’s report on the merger plan


Valuer’s report on the creditors’ position after merger


Extraordinary shareholder’s meeting March 30, 2023

Notice convening the extraordinary general meeting 


Live streaming of extraordinary shareholders’ meeting


Live streaming of extraordinary shareholders’ meeting (in Danish)


Resolutions from extraordinary shareholders’ meeting


Minutes from extraordinary shareholders’ meeting


Presentation

Investor presentation (December 12, 2022)


Conference call (December 12, 2022)


Other documents

Presentation of the Executive Leadership Team of the future combined company


Draft articles of association for Novozymes after completion of the Merger


Revised remuneration policy


Novozymes Remuneration Report 2022


Novozymes Articles of Association (March 30, 2023)


Novozymes annual reports

The Novozymes Annual Report 2022


The Novozymes Annual Report 2021


The Novozymes Annual Report 2020


The Novozymes Annual Report 2019


Chr. Hansen annual reports

The Chr. Hansen Annual Report 2021/2022


The Chr. Hansen Annual Report 2020/2021


The Chr. Hansen Annual Report 2019/2020


Factsheet

Contacts

Investor relations

Tobias Cornelius Björklund

Head of Investor relations
+45 3077 8682
tobb@novozymes.com

Media relations

Lina Danstrup

Head of External Communications
+45 3077 0552
lind@novozymes.com